Do I need a local agent for drug registration?

Yes. All three markets — KSA, UAE, and Egypt — require a licensed local agent or authorized representative. We provide local agent services and manage all authority correspondence on your behalf.

Can you handle post-approval variations?

Absolutely. We manage Type I and Type II variations, label updates, manufacturing site changes, renewals, and pharmacovigilance reporting throughout your product's market lifecycle.

What dossier format is required?

All three authorities accept CTD format submissions. KSA and UAE increasingly require eCTD. We prepare dossiers in the required electronic format with full Arabic labeling support.

Pharmaceutical Regulatory Affairs & Drug Registration in Saudi Arabia (SFDA)

All Services

Pharmaceuticals

Regulatory solutions and market access for drug products

Request Consultation

Overview

Comprehensive Pharmaceutical Regulatory Affairs Support

Navigate complex drug registration pathways with confidence. Our pharmaceutical regulatory affairs team in KSA manages CTD dossiers, pricing submissions, and post-approval variations across Saudi Arabia, the UAE, and Egypt.

With direct authority relationships and 400K+ product registrations completed, we accelerate time-to-market while ensuring full compliance with evolving MENA pharmaceutical regulations.

Key Focus Areas

New drug & generic registrations
Pricing & reimbursement strategy
Post-approval variations & renewals
Pharmacovigilance & lifecycle management

Capabilities

Core Capabilities

Specialized pharmaceuticals regulatory services designed for MENA market access and ongoing compliance.

Drug Registration

CTD dossier compilation, eCTD submissions, and authority correspondence for new and generic products.

Pricing & Reimbursement

Strategic pricing analysis and submission support aligned with SFDA, MOHAP, and EDA frameworks.

GMP & Quality Compliance

Manufacturing site approvals, GMP certificate verification, and quality agreement support.

Lifecycle Management

Variations, renewals, label updates, and pharmacovigilance reporting throughout product lifecycle.

Regulatory Intelligence

Real-time updates on guideline changes, submission requirements, and approval timelines.

Local Agent Services

Authorized representation, import licenses, and distributor qualification across MENA markets.

Our Process

Regulatory Process Timeline

Select your target market to view the authority-specific registration pathway for Saudi Arabia, the UAE, or Egypt.

Saudi Arabia·SFDA·Full regulatory lifecycle

Product Eligibility & Classification

1–2 weeks

Assess product type (NCE, generic, or biologic) against SFDA registration pathways, classification rules, and local agent requirements.

eCTD Dossier Preparation

4–8 weeks

Compile CTD Modules 1–5 in eCTD format, verify GMP certificates, stability data, and Arabic/English labeling for SFDA review.

SDR Portal Submission

2–4 weeks

Submit via the SFDA SDR/e-portal, coordinate local agent appointment, and manage initial administrative screening.

SFDA Technical & Scientific Review

6–12 months

Respond to deficiency letters, CMC queries, and pricing committee review until SFDA marketing authorization is granted.

Post-Marketing Compliance

Ongoing

Manage variations, renewals, pharmacovigilance reporting (PSUR/PBRER), and SFDA labeling updates throughout the product lifecycle.

Documentation

Required Documents

Select your target market to view the authority-specific documentation required for Saudi Arabia, the UAE, or Egypt.

Saudi Arabia·SFDA

SFDA Product Dossier

CTD Modules 1–5 in eCTD format
Certificate of Pharmaceutical Product (CPP)
GMP certificate of manufacturing site
Stability study reports (ICH-compliant)

Manufacturing & Quality

Batch manufacturing records and specifications
Analytical method validation reports
Site master file summary
Quality agreement with SFDA-authorized local agent

Labeling & Commercial

Proposed product labeling (Arabic/English)
Summary of product characteristics (SmPC)
SFDA pricing committee justification
SDR portal authorization and import license

Regional Coverage

Pharmaceuticals

Saudi Arabia · Egypt · UAE · MENA Region

SFDA

Saudi Arabia

Full regulatory lifecycle

Full Regulatory Process

We simplify your journey with the SFDA by handling every step of the regulatory process. From assessing product eligibility and organizing eCTD dossiers to handling submissions, variations, and renewals, we ensure full compliance and smooth approvals.

Read the full guide: SFDA Drug Registration in Saudi Arabia

Proactive Oversight

Our team proactively monitors regulatory updates, provides strategic insights, and communicates directly with the SFDA on your behalf.

Complete Compliance Support

Whether you need guidance on classification, labeling, or post-marketing requirements, we deliver end-to-end support that keeps your products compliant, competitive, and market-ready.

FAQ

Frequently Asked Questions

Common questions about pharmaceuticals regulatory requirements in KSA, UAE, and Egypt.

SFDA drug registration typically takes 6–12 months depending on product type, dossier completeness, and whether it is a new chemical entity or generic. Our team optimizes timelines through pre-submission gap analysis.

Read our guide to the SFDA Regulatory Framework for Drug Approval